Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients

A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key...

Descripción completa

Detalles Bibliográficos
Autores principales: Luque, Rafael, ALOthman, Zeid A., Balu, Alina M., Voskressensky, Leonid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587078/
https://www.ncbi.nlm.nih.gov/pubmed/34771146
http://dx.doi.org/10.3390/molecules26216738
_version_ 1784598027475877888
author Luque, Rafael
ALOthman, Zeid A.
Balu, Alina M.
Voskressensky, Leonid
author_facet Luque, Rafael
ALOthman, Zeid A.
Balu, Alina M.
Voskressensky, Leonid
author_sort Luque, Rafael
collection PubMed
description A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide.
format Online
Article
Text
id pubmed-8587078
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85870782021-11-13 Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients Luque, Rafael ALOthman, Zeid A. Balu, Alina M. Voskressensky, Leonid Molecules Perspective A perspective on the use of heterogeneous catalysis to drive the waste-to-pharma concept is provided in this contribution based on the conversion of furanics to active pharmaceutical ingredients (APIs). The provided overview of the concept in this perspective article has been exemplified for two key molecule examples: Ancarolol and Furosemide. MDPI 2021-11-08 /pmc/articles/PMC8587078/ /pubmed/34771146 http://dx.doi.org/10.3390/molecules26216738 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Perspective
Luque, Rafael
ALOthman, Zeid A.
Balu, Alina M.
Voskressensky, Leonid
Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
title Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
title_full Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
title_fullStr Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
title_full_unstemmed Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
title_short Heterogeneous Catalysis to Drive the Waste-to-Pharma Concept: From Furanics to Active Pharmaceutical Ingredients
title_sort heterogeneous catalysis to drive the waste-to-pharma concept: from furanics to active pharmaceutical ingredients
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8587078/
https://www.ncbi.nlm.nih.gov/pubmed/34771146
http://dx.doi.org/10.3390/molecules26216738
work_keys_str_mv AT luquerafael heterogeneouscatalysistodrivethewastetopharmaconceptfromfuranicstoactivepharmaceuticalingredients
AT alothmanzeida heterogeneouscatalysistodrivethewastetopharmaconceptfromfuranicstoactivepharmaceuticalingredients
AT balualinam heterogeneouscatalysistodrivethewastetopharmaconceptfromfuranicstoactivepharmaceuticalingredients
AT voskressenskyleonid heterogeneouscatalysistodrivethewastetopharmaconceptfromfuranicstoactivepharmaceuticalingredients

Ejemplares similares